These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 695693)

  • 1. Metabolism of the antimicrobial agent nibroxane, 5-bromo-2-methyl-5-nitro-m-dioxane, in the rat.
    Sullivan HR; Marshall FJ; Bopp RJ
    Xenobiotica; 1978 Aug; 8(8):495-502. PubMed ID: 695693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dose-dependent fate of 1,4-dioxane in rats.
    Young JD; Braun WH; Gehring PJ
    J Environ Pathol Toxicol; 1978; 2(2):263-82. PubMed ID: 739213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and metabolism of idazoxan in the rat.
    Lewis CJ; Havler ME; Humphrey MJ; Lloyd-Jones JG; McCleavy MA; Muir NC; Waltham K
    Xenobiotica; 1988 May; 18(5):519-32. PubMed ID: 2899932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent fate of 1,4-dioxane in rats.
    Young JD; Braun WH; Gehring PJ
    J Toxicol Environ Health; 1978; 4(5-6):709-26. PubMed ID: 731724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of l-3-[(dimethylamino)-(m-dioxan-5-yl)methyl]pyridine in man.
    Rubin A; Dhahir PH; Crabtree RE; Henry DP
    Drug Metab Dispos; 1979; 7(3):149-54. PubMed ID: 38085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 1,4-dioxane in humans.
    Young JD; Braun WH; Rampy LW; Chenoweth MB; Blau GE
    J Toxicol Environ Health; 1977 Oct; 3(3):507-20. PubMed ID: 926203
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotransformation of 4'-ethynl-2-fluorobiphenyl in the rat. In vitro and in vivo studies.
    Sullivan HR; Roffey P; McMahon RE
    Drug Metab Dispos; 1979; 7(2):76-80. PubMed ID: 38077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition kinetics, metabolism and urinary excretion of sulfathiazole following oral administration in sheep.
    Jain SK; Hapke HJ
    Dtsch Tierarztl Wochenschr; 1995 Oct; 102(10):394-5. PubMed ID: 8591739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.
    Patel DK; Woolley JL; Shcokcor JP; Johnson RL; Taylor LC; Sigel CW
    Drug Metab Dispos; 1991; 19(2):491-7. PubMed ID: 1676660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
    Fukano Y; Kawazu K
    Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of route of administration of dioxane on hepatic mixed function oxidase enzymes in mice.
    Mungikar AM; Pawar SS
    Indian J Exp Biol; 1979 Feb; 17(2):174-6. PubMed ID: 478584
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and disposition of moxonidine in Fischer 344 rats.
    He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
    Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat.
    Chu I; Villeneuve DC; Secours V; Franklin C; Rock G; Viau A
    Drug Metab Dispos; 1978; 6(2):146-9. PubMed ID: 26529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin.
    Yourick JJ; Bronaugh RL
    Toxicol Appl Pharmacol; 2000 Jul; 166(1):13-23. PubMed ID: 10873714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of sulfathiazole in rumen fluid and its metabolism and disposition kinetics following intraruminal administration in sheep.
    Jain SK; Hapke HJ
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):193-5. PubMed ID: 8593771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.